Related Experiment Video
Updated: Jul 15, 2025
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Organizing pneumonia and COVID-19
Carolina Rodrigues Tonon1, Suzana Erico Tanni1, Juliana Rocha1
1Internal Medicine Department, Botucatu Medical School, Sao Paulo State University, UNESP, Sao Paulo, Brazil.
Organizing pneumonia (OP) is an interstitial lung disease that can arise after COVID-19. Early diagnosis and treatment with prednisone can resolve lung abnormalities, improving patient outcomes.
Area of Science:
- Pulmonology
- Infectious Diseases
- Radiology
Background:
- Organizing pneumonia (OP) is an interstitial lung disease with cryptogenic or secondary causes.
- Persistent inflammation from COVID-19 can lead to interstitial lung disease.
Observation:
- A 38-year-old male with severe COVID-19 requiring prolonged mechanical ventilation developed persistent respiratory symptoms.
- Chest CT scans revealed diffuse bilateral ground-glass opacities and consolidation.
- Organizing pneumonia was suspected based on clinical and imaging findings.
Findings:
- The patient received a six-month course of prednisone (40 mg/day).
- Treatment resulted in the resolution of both functional and imaging abnormalities.
- Organizing pneumonia is a potential complication in COVID-19 patients with persistent respiratory issues.
Implications:
- Organizing pneumonia should be considered in the differential diagnosis of post-COVID-19 respiratory complications.
- Prompt diagnosis and treatment can lead to favorable outcomes in these patients.
- This highlights the importance of multidisciplinary approaches in managing severe COVID-19 sequelae.
More Related Videos
03:53Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...